Heil J, Kuerer HM, Pfob A, et al. Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges. Ann Oncol. 2020;31:61–71.

Article  CAS  PubMed  Google Scholar 

Heil J, Kummel S, Schaefgen B, et al. Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques. Br J Cancer. 2015;113:1565–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuerer HM, Rauch GM, Krishnamurthy S, et al. A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy. Ann Surg. 2018;267:946–51.

Article  PubMed  Google Scholar 

Tasoulis MK, Lee HB, Yang W, et al. Accuracy of post-neoadjuvant chemotherapy image-guided breast biopsy to predict residual cancer. JAMA Surg. 2020;155:e204103.

Article  PubMed  PubMed Central  Google Scholar 

Kataoka A, Sawaki M, Horisawa N, et al. The absence of cancer in the location of a breast tissue marker after neoadjuvant chemotherapy may predict pathological complete response with high accuracy: Results from a phase II trial. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13199-8.

Article  Google Scholar 

Kuerer HM, Smith BD, Krishnamurthy S, et al. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2022;23:1517–24.

Article  PubMed  Google Scholar